help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LAVORINI, F.
Right arrow Articles by PISTOLESI, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LAVORINI, F.
Right arrow Articles by PISTOLESI, M.

Am. J. Respir. Crit. Care Med., Volume 163, Number 5, April 2001, 1117-1120

Fog-induced Respiratory Responses Are Attenuated by Nedocromil Sodium in Humans

FEDERICO LAVORINI, GIOVANNI A. FONTANA, TITO PANTALEO, GIANNA CAMICIOTTOLI, WALTER CASTELLANI, NAZZARENA M. MALUCCIO, and MASSIMO PISTOLESI

Dipartimento di Area Critica Medico Chirurgica, Sezione di Medicina Respiratoria, Università di Firenze, Florence, Italy

Fog inhalation induces cough and bronchoconstriction in patients with asthma, but only cough in normal subjects; whether it also influences the pattern of breathing is unclear. Nedocromil sodium (NCS) inhibits the cough response to inhalation of several pharmacological agents but its effects on fog-induced cough and changes in the pattern of breathing are unknown. We evaluated the effects of no drug, placebo, and 4- and 8-mg NCS administration on the cough threshold and changes in the pattern of breathing during fog inhalation in 14 healthy subjects. Measurements of tidal volume (VT), duration of inspiratory and expiratory times (TI and TE, respectively), total duration of the respiratory cycle (TT), mean inspiratory flow (VT/TI), duty cycle (TI/TT), respiratory frequency (f, 60/TT), and inspiratory minute ventilation (V I) were obtained by inductive plethysmography. Median cough threshold values were unaffected by placebo, but were increased (p < 0.01) by both NCS doses. In no-drug and placebo trials, inhalation of the threshold fog concentration caused increases in both VT/TI and V I (p always < 0.05) due to selective increases (p < 0.01) in VT. These changes were markedly attenuated by both NCS doses administration. Thus, fog induces coughing and increases in VT, VT/ TI, and V I in healthy subjects; NCS possesses antitussive effects and attenuates fog-induced changes in the pattern of breathing, possibly through inhibition of rapidly adapting "irritant" receptors.




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
F. Lavorini, G. A. Fontana, T. Pantaleo, P. Geri, R. Piumelli, M. Pistolesi, and J. Widdicombe
Fog-induced Cough with Impaired Respiratory Sensation in Congenital Central Hypoventilation Syndrome
Am. J. Respir. Crit. Care Med., October 15, 2007; 176(8): 825 - 832.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. H. Morice, G. A. Fontana, M. G. Belvisi, S. S. Birring, K. F. Chung, P. V. Dicpinigaitis, J. A. Kastelik, L. P. McGarvey, J. A. Smith, M. Tatar, et al.
ERS guidelines on the assessment of cough
Eur. Respir. J., June 1, 2007; 29(6): 1256 - 1276.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2001 American Thoracic Society 		  ATS Best of the Web